Literature DB >> 12106722

Results of hydrophilic acrylic, hydrophobic acrylic, and silicone intraocular lenses in uveitic eyes with cataract: comparison to a control group.

Claudette Abela-Formanek1, Michael Amon, Jörg Schauersberger, Andreas Kruger, Johannes Nepp, Gebtraud Schild.   

Abstract

PURPOSE: To evaluate the uveal and capsular biocompatibility of hydrophilic acrylic, hydrophobic acrylic, and silicone intraocular lenses (IOLs) in eyes with uveitis.
SETTING: Department of Ophthalmology, University of Vienna, Vienna, Austria.
METHODS: This prospective study comprised 72 eyes with uveitis and 68 control eyes having phacoemulsification and IOL implantation by 1 surgeon. Patients received 1 of the following IOLs: foldable hydrophilic acrylic (Hydroview, Bausch & Lomb), hydrophobic acrylic (AcrySof, Alcon), or silicone (CeeOn 911, Pharmacia). Postoperative evaluations were at 1, 3, and 7 days and 1, 3, and 6 months. Cell reaction was evaluated by specular microscopy of the anterior IOL surface and the anterior and posterior capsule reaction, by biomicroscopy.
RESULTS: Small round cell deposition was observed on all IOLs in the immediate postoperative period, especially in eyes with uveitis. This reaction decreased 3 to 6 months after surgery. Although the CeeOn 911 had a higher mean grade of small cells, there was no statistical difference between the 3 IOL types after 6 months in the uveitis and control groups. Foreign-body giant cells (FBGCs) increased after 1 week to 1 month. The AcrySof IOLs had the highest number of FBGCs; after 6 months, there was a statistically significant difference between the AcrySof and Hydroview uveitis groups (P =.036) and the AcrySof and CeeOn 911 uveitis groups (P =.003) but there was no difference among the 3 IOL types in the control group. Lens epithelial cell outgrowth persisted on the Hydroview IOLs in control eyes and regressed on all 3 IOL types in uveitic eyes and on the AcrySof and CeeOn 911 IOLs in control eyes (P =.0001). Anterior capsule opacification (ACO) was more severe on all IOL types in uveitic eyes and on the CeeOn 911 IOL in control eyes. Posterior capsule opacification (PCO) was more severe in uveitic eyes. The Hydroview group had more severe PCO than the AcrySof and the CeeOn 911 groups in uveitis and control eyes. Six months postoperatively, the difference was significant (P =.0001). There was no significant difference between the AcrySof and CeeOn 911 IOLs.
CONCLUSIONS: Intraocular lens biocompatibility is inversely related to inflammation. Hydrophilic acrylic material had good uveal but worse capsular biocompatibility. Hydrophobic acrylic material had lower uveal but better capsular biocompatibility. Silicone showed a higher small cell count (mild) and more severe ACO but achieved PCO results comparable to FBGC results and better than those with the AcrySof lens 6 months after surgery. Despite the differences in IOL biocompatibility, all patients benefited from the surgery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12106722     DOI: 10.1016/s0886-3350(02)01425-6

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  28 in total

1.  Phacoemulsification and Core Vitrectomy in Fuchs' Heterochromic Uveitis.

Authors:  Sadullah Keles; Osman Ondas; Orhan Ates; Metin Ekinci; Baki Kartal; Eren Arpali; Kenan Yildirim; Erdinc Ceylan; Orhan Baykal
Journal:  Eurasian J Med       Date:  2017-06

2.  Nd:YAG capsulotomy rates after use of the AcrySof acrylic three piece and one piece intraocular lenses.

Authors:  S I Mian; K Fahim; A Marcovitch; H Gada; D C Musch; A Sugar
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

3.  Prospective, non-randomised, long term clinical evaluation of a foldable hydrophilic single piece intraocular lens: results of the Centerflex FDA study.

Authors:  K A Becker; M Martin; T M Rabsilber; B B Entz; A J Reuland; G U Auffarth
Journal:  Br J Ophthalmol       Date:  2006-05-10       Impact factor: 4.638

4.  Outcome of phacoemulsification in patients with uveitis.

Authors:  M A Elgohary; P J McCluskey; H M A Towler; N Okhravi; R P Singh; R Obikpo; S S Lightman
Journal:  Br J Ophthalmol       Date:  2007-01-17       Impact factor: 4.638

5.  Effect of four different intraocular lenses on posterior capsule opacification.

Authors:  Rahmi Duman; Fatih Karel; Pelin Özyol; Can Ateş
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

Review 6.  Types of intraocular lenses for cataract surgery in eyes with uveitis.

Authors:  Theresa G Leung; Kristina Lindsley; Irene C Kuo
Journal:  Cochrane Database Syst Rev       Date:  2014-03-04

7.  Clinical outcomes of combined pars plana vitrectomy and trans-scleral 4-point suture fixation of a foldable intraocular lens.

Authors:  Neha Goel
Journal:  Eye (Lond)       Date:  2018-02-05       Impact factor: 3.775

8.  Comparison of orbital floor triamcinolone acetonide and oral prednisolone for cataract surgery management in patients with non-infectious uveitis.

Authors:  Martin Roesel; Carsten Heinz; Joerg Michael Koch; Arnd Heiligenhaus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-01-16       Impact factor: 3.117

9.  Adherence and viability of porcine lens epithelial cells on three different IOL materials in vitro.

Authors:  Yvonne Hesse; Jürgen Kampmeier; Gerhard K Lang; Alicia Baldysiak-Figiel; Gabriele E Lang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-08-23       Impact factor: 3.117

10.  Cataract surgery in patients with history of uveitis.

Authors:  Ujwala Baheti; Sana S Siddique; C Stephen Foster
Journal:  Saudi J Ophthalmol       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.